首页> 外文OA文献 >A Method for Content Uniformity Determination of Atenolol and Losartan Potassium in Combined Tablet Dosage Form
【2h】

A Method for Content Uniformity Determination of Atenolol and Losartan Potassium in Combined Tablet Dosage Form

机译:片剂联合剂型中阿替洛尔和氯沙坦钾的含量均匀度测定方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A simple, accurate, rapid, specific and reproducible UV spectrophotometric method was developed for estimation of content uniformity of atenolol and losartan potassium in its combined tablet dosage form. The method involves formation and solving the simultaneous equation using 226.4 and 254 nm as two wavelengths for atenolol and losartan, respectively. Developed method was employed to determine the atenolol and losartan content in ten individual tablet units of five market formulations. Methanol was used as solvent. The method was validated. From the results, it was concluded that all brands are within the content uniformity limit, 85-115%.
机译:开发了一种简单,准确,快速,特异且可重现的紫外分光光度法,用于评估阿替洛尔和氯沙坦钾在其组合片剂剂型中含量的均匀性。该方法涉及形成和求解联立方程,分别使用226.4和254 nm作为阿替洛尔和氯沙坦的两个波长。采用发达的方法测定五种市场配方的十个独立片剂单位中的阿替洛尔和氯沙坦含量。甲醇用作溶剂。该方法已经过验证。从结果可以得出结论,所有品牌均在含量均匀度极限(85-115%)之内。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号